COVID-19 cases continue to rise in India, the Russian ambassador, Nikolay Kudashev, said Russia is talking to the Indian government "on different levels" about cooperation that may include "supplies, co-development and co-production" of Sputnik V.

WION Dispatch: India cautiously studying Russian proposal for COVID-19 vaccine

Russia in talks with India to produce Sputnik V

India studying Russian proposal for COVID-19 vaccine

Patients involved in early tests of a Russian coronavirus vaccine developed antibodies with "no serious adverse events", according to research published in The Lancet Friday, but experts said the trials were too small to prove safety and effectiveness.

COVID-19: Russia vaccine 'passes early trial test'

Russia's deputy Prime Minister Tatiana Golikova on Wednesday said that the country is preparing to approve a second vaccine 'EpiVacCorona' against the novel coronavirus in late September or early October.

Russia's deputy Prime Minister Tatiana Golikova on Wednesday said that the country is preparing to approve a second vaccine 'EpiVacCorona' against the novel coronavirus in late September or early October. Also read: Women may mount stronger COVID-19 immune response During the televised government meet, Golikova told Russian President Vladimir Putin that the vaccine developed by the Vector virology institute will complete its early-stage clinical trials in Siberia by the end of September. “As of today there have been no complications among those vaccinated in the first and second stages of testing,” she said. Also read: Chemical present in insect spray can kill coronavirus: Study Earlier this month, Russia became the first country to grant regulatory approval to a COVID-19 vaccine after less than two months of human testing. This vaccine was called "Sputnik V", to pay their homage to the world’s first satellite launched by the Soviet Union. The Russian authorities have hailed "Sputnik V" safe and effective. However, the experts in the west have been doubtful of the vaccine and have warned against its use until all internationally approved testing and regulatory steps have been taken. According to RDIF, Russia’s sovereign wealth fund, the final phase of clinical trials on “Sputnik V” were beginning. It said 40,000 people would take part in the final trials and that similar trials would also be carried out in five other countries. (Inputs from Reuters)

'EpiVacCorona': Now, Russia readies approval for second COVID-19 vaccine

The Russian government has reached out to India seeking collaboration for manufacturing its COVID-19 vaccine 'Sputnik V' and conducting its phase 3 clinical trial here, sources said.

According to government sources, the matter was discussed by the national expert group on vaccine administration for COVID-19 in its last meeting held on August 22.

Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with Russian Direct Investment Fund (RDIF).

The vaccine has not been tested in phase 3 or larger clinical trials.

There has been scepticism in some quarters about limited data related to the efficacy of the vaccine.

"The Russian government has reached out to the Indian government seeking a collaboration for manufacturing their COVID-19 vaccine, Sputnik V, and conducting its phase 3 trial here, a source in the government said.

"The Department of Biotechnology (DBT) along with the Department of Health Research has been asked to lead and look into the matter.

They (Russian government officials) have shared some information and data on Sputnik V, while more data related to the safety and efficacy of the vaccine is awaited," the source said.

When asked if the Russian government has placed any formal request for the manufacture of its COVID-19 vaccine in India, Union Health Secretary Rajesh Bhushan said at a press conference, "As far as Sputnik V vaccine is concerned, both India and Russia are in communication. Some initial information has been shared while some detailed information is awaited."

According to sources, Russian Ambassador to India Nikolay Kudashev has approached the office of Principal Scientific Advisor K VijayRaghavan as well as secretaries of the departments of biotechnology and health research in this regard.

The Russian government has reached out to India seeking collaboration for manufacturing its COVID-19 vaccine 'Sputnik V' and conducting its phase 3 clinical trial here, sources said.

The Russian government has reached out to India seeking collaboration for manufacturing its COVID-19 vaccine 'Sputnik V' and conducting its phase 3 clinical trial here, sources said. According to government sources, the matter was discussed by the national expert group on vaccine administration for COVID-19 in its last meeting held on August 22. Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with Russian Direct Investment Fund (RDIF). The vaccine has not been tested in phase 3 or larger clinical trials. There has been scepticism in some quarters about limited data related to the efficacy of the vaccine. "The Russian government has reached out to the Indian government seeking a collaboration for manufacturing their COVID-19 vaccine, Sputnik V, and conducting its phase 3 trial here, a source in the government said. "The Department of Biotechnology (DBT) along with the Department of Health Research has been asked to lead and look into the matter. They (Russian government officials) have shared some information and data on Sputnik V, while more data related to the safety and efficacy of the vaccine is awaited," the source said. When asked if the Russian government has placed any formal request for the manufacture of its COVID-19 vaccine in India, Union Health Secretary Rajesh Bhushan said at a press conference, "As far as Sputnik V vaccine is concerned, both India and Russia are in communication. Some initial information has been shared while some detailed information is awaited." According to sources, Russian Ambassador to India Nikolay Kudashev has approached the office of Principal Scientific Advisor K VijayRaghavan as well as secretaries of the departments of biotechnology and health research in this regard.

Russia seeks collaboration with India for manufacturing COVID-19 vaccine Sputnik V: Sources

Russian President Vladamir Putin proudly announced the approval of the world's first COVID-19 vaccine. A Russian doctor has raised some concerns over the use of vaccines. Watch report.

COVID-19 Pandemic: Russian doctor flags concerns regarding use of Sputnik V

While there is a lot of talk about a Wuhan virus vaccine, an important question that has been raised is that is it a vaccine or a stunt?

Experts question Russia's COVID-19 vaccine claims

sputnik-v

Sputnik V, News on Sputnik V, stories on Sputnik V, articles on Sputnik V, Sputnik V stories at Wion, Sputnik V news, Sputnik V latest news

sputnik v